Choksi Laboratories Ltd
₹207.75
-1.45 (0.69%)
Mon, 02 Nov 2026, 02:04 am
Commercial Services
Miscellaneous Commercial Services
24.5KChoksi Laboratories Ratios
| Particulars | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 2.16 | 8.81 | 6.85 | 6.48 | 5.39 | 3.35 | 5.96 | 10.58 | 13.32 | 13.42 | 6.11 | 0 | 0 | 85.46 | 7.26 | 26.60 | 54.94 |
| Price to book ratio | 0.26 | 0.65 | 0.53 | 0.40 | 0.29 | 0.19 | 0.27 | 0.38 | 0.56 | 0.81 | 0.41 | 0.28 | 0.31 | 0.99 | 1.10 | 1.33 | 3.55 |
| Price to sales ratio | 0.31 | 0.77 | 0.62 | 0.43 | 0.32 | 0.20 | 0.24 | 0.34 | 0.47 | 0.59 | 0.29 | 0.20 | 0.21 | 0.59 | 0.68 | 0.80 | 2 |
| Price to cash flow ratio | 2.06 | 2.91 | 0 | 2.26 | 3.66 | 1.48 | 5.83 | 1.39 | 2.12 | 3.60 | 1.75 | 4.52 | 1.55 | 3.70 | 4.70 | 3.39 | 9.11 |
| Enterprise value | 6.24Cr | 10.93Cr | 15.58Cr | 12.74Cr | 13.14Cr | 14.74Cr | 16.11Cr | 20.41Cr | 22.5Cr | 29.51Cr | 29.32Cr | 38.84Cr | 44.34Cr | 54.57Cr | 55.1Cr | 59.73Cr | 112Cr |
| Enterprise value to EBITDA ratio | 2.16 | 3.67 | 4.39 | 3.38 | 3.34 | 3.46 | 3.15 | 3.93 | 4.68 | 4.66 | 4.03 | 10.94 | 10.60 | 6.08 | 5.35 | 5.81 | 9.90 |
| Debt to equity ratio | 0.40 | 0.30 | 0.55 | 0.44 | 0.49 | 0.56 | 0.60 | 0.68 | 0.53 | 0.55 | 0.82 | 1.66 | 2.21 | 2.08 | 1.54 | 1.39 | 1.24 |
| Return on equity % | 0 | 7.83 | 8.16 | 5.99 | 5.58 | 5.95 | 4.45 | 3.67 | 4.34 | 6.22 | 6.90 | -17.57 | -13.74 | 1.16 | 16.46 | 5.12 | 6.65 |
Choksi Laboratories Ltd Ratios
The Choksi Laboratories Ltd Ratios page provides a complete fundamental analysis of Choksi Laboratories Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Choksi Laboratories Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.
Choksi Laboratories Ltd (NSE: , BSE: 526546) is currently trading at ₹207.75, with a market capitalization of ₹144.7Cr. As a major player in the Commercial services sector and Miscellaneous commercial services industry, Choksi Laboratories Ltd remains a key stock for fundamental analysis using Choksi Laboratories Ltd Ratios.
Choksi Laboratories Ltd Ratios: Valuation Overview
Price to Earnings Ratio (P/E)
The Choksi Laboratories Ltd P/E ratio currently stands at 54.94, making it one of the most tracked metrics in Choksi Laboratories Ltd Ratios.
Historically, the Choksi Laboratories Ltd P/E ratio has shown strong fluctuations:
- 2025: 54.94
- 2024: 26.60
- 2023: 7.26
- 2022: 85.46
- 2021: 0
The rising Choksi Laboratories Ltd P/E ratio indicates increasing investor confidence and premium valuation.
Price to Book Ratio (P/B)
The Choksi Laboratories Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 3.55.
Historical P/B trend:
- 2025: 3.55
- 2024: 1.33
- 2023: 1.10
- 2022: 0.99
Choksi Laboratories Ltd is trading at a premium to its book value, indicating strong market confidence.
Price to Sales Ratio (P/S)
The Choksi Laboratories Ltd P/S ratio currently stands at 2, an important part of Choksi Laboratories Ltd Ratios for revenue valuation.
Historical P/S ratio:
- 2025: 2
- 2024: 0.80
- 2023: 0.68
- 2022: 0.59
The rising Choksi Laboratories Ltd P/S ratio indicates improved revenue valuation by investors.
Choksi Laboratories Ltd Price to Cash Flow Ratio (P/CF)
The Choksi Laboratories Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 9.11.
Historical Choksi Laboratories Ltd Price to Cash Flow Ratio:
- 2025: 9.11
- 2024: 3.39
- 2023: 4.70
- 2022: 3.70
- 2021: 1.55
The rising Choksi Laboratories Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.
Choksi Laboratories Ltd Enterprise Value Ratios
Enterprise Value (EV)
The Choksi Laboratories Ltd EV currently stands at ₹112Cr, representing the total company valuation including debt.
Historical EV trend:
- 2025: 112Cr
- 2024: 59.73Cr
- 2023: 55.1Cr
- 2022: 54.57Cr
Choksi Laboratories Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.
EV/EBITDA Ratio
The Choksi Laboratories Ltd EV/EBITDA ratio is currently 9.90, a key metric in Choksi Laboratories Ltd Ratios to assess valuation relative to earnings.
Historical EV/EBITDA:
- 2025: 9.90
- 2024: 5.81
- 2023: 5.35
- 2022: 6.08
Higher Choksi Laboratories Ltd EV/EBITDA suggests premium valuation.
Choksi Laboratories Ltd Financial Strength Ratios
Debt to Equity Ratio (D/E)
The Choksi Laboratories Ltd D/E ratio is currently 1.24, reflecting leverage and financial stability.
Historical D/E:
- 2025: 1.24
- 2024: 1.39
- 2023: 1.54
- 2022: 2.08
Higher D/E ratio indicates rising financial risk.
Return on Equity (ROE %)
The Choksi Laboratories Ltd ROE currently stands at 6.65%, showing profitability and capital efficiency.
Historical ROE:
- 2025: 6.65
- 2024: 5.12
- 2023: 16.46
- 2022: 1.16
Declining ROE indicates pressure on profitability.
Choksi Laboratories Ltd Ratios Analysis Summary
The Choksi Laboratories Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Choksi Laboratories Ltd stock is undervalued, fairly valued, or overvalued.
Tracking Choksi Laboratories Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.
